Skip to content
DataLookout
Start free
Menu

NCT06140719

xPedite: A Study to Expedite DIPG and DMG Research

StatusWithdrawn
PhaseNot specified
SponsorxCures
Primary completion
Track this trial

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Record History

All 6 versions: 6 with changes below. See every version on ClinicalTrials.gov ↗

  1. Trial status changed: Recruiting → Withdrawn Sponsor's reason: Protocol termination Show 4 more changesShow less
    • Enrollment target: estimated 400 to confirmed 0
    • Primary completion date changed from estimate of Sep 2026 to Oct 14, 2024
    • Eligibility criteria expanded, about 7 words
    • Site details revised
  2. Primary endpoint revised
    • Secondary endpoints: 3 to 2
    v5
  3. Collaborators shortened, about 2 wordsv4
  4. Trial status: Not Yet Recruiting to Recruiting
    • Start date changed from estimate of Nov 2023 to Nov 1, 2023
    • Site details revised
    v3
  5. Study title shortened, about 1 wordv2
  6. Study First Submitted
  • Stopped: terminated, suspended or withdrawn
  • Notable: the plan changed
  • Minor: routine updates

Endpoints

Primary

Overall Survival (OS)
Timeframe: 12 months

Secondary (2)

Objective Response Rate (ORR)
Clinical Benefit Rate (CBR)

Sites

1 site in 1 country

  • xCures, Inc.Los Altos, California, United States